Appendix 4D and Half Year Report
Filed with ASX · · 29 pages · English
There were no dividends paid, recommended or declared during the current financial period. Previous period There were no dividends paid, recommended or declared during the previous financial period. 5. Foreign entities Details of origin of accounting standards used in compiling the report: Not applicable. Lumos Diagnostics Holdings Limited and its subsidiaries, including its foreign subsidiaries,
Lumos Diagnostics Holdings Ltd. on 6ix
Story so far
Earlier from Lumos Diagnostics
- Lumos Completes Enrolment Milestone for Paediatric Study
- Quarterly Activities/Appendix 4C Cash Flow Report
- Lumos Secures 100% US Medicare Reimbursement for FebriDx
- Lumos secures follow-on PKU contract with Aptatek
- LDX & BARDA partner on new US$6.2m FebriDx Paediatric Study
Later from Lumos Diagnostics
- Lumos Delivers Several Pivotal Milestones in 1H FY26
- Trading Halt
- US FDA Grants CLIA Waiver for FebriDx
- Lumos completes $20m placement and launches SPP
- Investor Presentation
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics